Mabtas 500 mg Infusion (Rituximab) – Wholesale Pharma Exporter from India

Mabtas 500 mg Infusion (Rituximab) contains Rituximab and is supplied for global pharmaceutical distribution. We export high-quality, export-grade medicines to international markets including the USA, UK, Europe, Africa, Southeast Asia, and Latin America.

Product Overview

This formulation is manufactured in WHO-GMP compliant facilities and is suitable for hospital supply, pharmacy distribution, institutional procurement, and long-term wholesale partnerships.

Why Source from Us?

• Bulk supply capability
• Competitive wholesale pricing
• Export documentation support
• Private labeling / OEM options
• Reliable global logistics

Target Markets

Ideal for pharma distributors, importers, government tenders, NGOs, online pharmacy resellers, and international sourcing agents looking for trusted pharmaceutical exporter from India.

Contact us today for bulk inquiries, MOQs, pricing details, and long-term supply agreements.